Nir Sassi

CIK: 0001760673

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (77.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDP

Indaptus Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

INDP
Indaptus Therapeutics, Inc.
Dec 22, 2025
Award(A)
Direct
26.8K shares at avg. $2.03$54K
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
1.3K shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
1.1K shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
2.5K shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
500 shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
500 shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
41 shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Apr 10, 2025
Disposition(D)
Stock Option (right to buy)
Direct
1.1K shares at avg. $0.07-
INDP
Indaptus Therapeutics, Inc.
Oct 9, 2024
Award(A)
Stock Option (Right to Buy)
Direct
75K shares-

		Type	Shares	Price		Ownership
Dec 22, 2025	INDP Indaptus Therapeutics, Inc.	Award(A)	26,758	$2.03	$54,319	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	1,250	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	1,125	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	2,500	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	500	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	500	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	41	$0.07	-	Direct
Apr 10, 2025	INDP Indaptus Therapeutics, Inc.	Disposition(D) Stock Option (right to buy)	1,125	$0.07	-	Direct
Oct 9, 2024	INDP Indaptus Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	75,000	-	-	Direct

1-9 of 9 transactions

About Sassi Nir

Sassi Nir (SEC CIK 0001760673) files insider reports with the SEC as Chief Financial Officer of Indaptus Therapeutics, Inc. (INDP).

Signal8 holds 3 ownership filings by Sassi Nir, all Form 4s, filed between Oct 10, 2024 and Dec 29, 2025. Those filings report 9 transactions, from Oct 9, 2024 to Dec 22, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Sassi Nir's filings is in NEW YORK, NY.

Recent filings by Sassi Nir

Dec 22, 2025: Grant or award of INDP shares (Form 4, code A).
Apr 10, 2025: Disposition to issuer transactions of INDP derivative securities (7 lines, Form 4, code D).
Oct 9, 2024: Grant or award of INDP derivative securities (Form 4, code A).

Other insiders filing for Indaptus Therapeutics, Inc. (INDP)

Lu Qinglai, Director
Yao Yun, 10% Owner
SINO LION VENTURES Ltd, 10% Owner
Dai Junyi, Chief Executive Officer
Lazar David E., Director
Jabbour Jerome D, Director

How to read Form 4 transaction codes